Michael Egan

Michael Egan is currently the Acting CEO and Chief Scientific Officer at CastleVax. Prior to this role, Michael held leadership positions at various pharmaceutical companies including Aurobindo Pharma USA, AuroVaccines a Division of AuroPharma USA, Bill & Melinda Gates Medical Research Institute, Takeda, Profectus BioSciences, Inc, and Wyeth Research. Michael's educational background includes a Ph.D. in Immunology from The Johns Hopkins University School of Medicine and a B.S. in Chemistry from Northern Arizona University. Michael also served in the United States Marine Corps as a Corporal.